| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 10965113 | Vaccine | 2015 | 6 Pages | 
Abstract
												Orally-delivered vaccines can provide long-term immune responses mucosally and systemically. For sexually-transmitted diseases that can be acquired at mucosal surfaces, such as HBV, an oral delivery platform may provide added protection over a conventional parenterally administered vaccine.
											Keywords
												
											Related Topics
												
													Life Sciences
													Immunology and Microbiology
													Immunology
												
											Authors
												Celine A. Hayden, Maria E. Fischer, Bryan L. Andrews, Hayley C. Chilton, Debra D. Turner, John H. Walker, Ian R. Tizard, John A. Howard, 
											